1. Home
  2. RDHL vs PNBK Comparison

RDHL vs PNBK Comparison

Compare RDHL & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • PNBK
  • Stock Information
  • Founded
  • RDHL 2009
  • PNBK 1999
  • Country
  • RDHL Israel
  • PNBK United States
  • Employees
  • RDHL N/A
  • PNBK N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • PNBK Major Banks
  • Sector
  • RDHL Health Care
  • PNBK Finance
  • Exchange
  • RDHL Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • RDHL 8.6M
  • PNBK 7.3M
  • IPO Year
  • RDHL N/A
  • PNBK N/A
  • Fundamental
  • Price
  • RDHL $6.99
  • PNBK $2.15
  • Analyst Decision
  • RDHL
  • PNBK
  • Analyst Count
  • RDHL 0
  • PNBK 0
  • Target Price
  • RDHL N/A
  • PNBK N/A
  • AVG Volume (30 Days)
  • RDHL 21.2K
  • PNBK 39.0K
  • Earning Date
  • RDHL 12-27-2024
  • PNBK 11-19-2024
  • Dividend Yield
  • RDHL N/A
  • PNBK N/A
  • EPS Growth
  • RDHL N/A
  • PNBK N/A
  • EPS
  • RDHL N/A
  • PNBK N/A
  • Revenue
  • RDHL $3,707,000.00
  • PNBK $27,300,000.00
  • Revenue This Year
  • RDHL $224.90
  • PNBK N/A
  • Revenue Next Year
  • RDHL $82.69
  • PNBK N/A
  • P/E Ratio
  • RDHL N/A
  • PNBK N/A
  • Revenue Growth
  • RDHL N/A
  • PNBK 3.61
  • 52 Week Low
  • RDHL $6.35
  • PNBK $1.39
  • 52 Week High
  • RDHL $43.50
  • PNBK $4.70
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 42.91
  • PNBK 50.80
  • Support Level
  • RDHL $7.09
  • PNBK $2.07
  • Resistance Level
  • RDHL $7.44
  • PNBK $2.45
  • Average True Range (ATR)
  • RDHL 0.53
  • PNBK 0.35
  • MACD
  • RDHL -0.03
  • PNBK -0.03
  • Stochastic Oscillator
  • RDHL 12.36
  • PNBK 27.69

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: